MedsWatch is an informal group of academic researchers and others interested in using data to reduce the risk of people being exposed to poor quality medicines. It’s also the name we’ve given to a system that aims to use market and other information to predict which medicines are at particularly high risk for being fake (falsified medicine), and which are most likely to have been badly made or to have degraded, so that when they reach the patient they don’t work the way they should (substandard medicine).
This blog is a repository for some of our thoughts and observations, as well as a place to share data, news stories and ideas related to medicine quality. We welcome contributions from other researcher, regulators, or colleagues past, present or future.
A lot of the work we do is in Indonesia, where we have been funded by the UK Department of Health and Social Care, through the National Institute for Health Research, to try out some of our ideas. Our main research programme, STARmeds, is led by the Faculty of Pharmacy at Univeristas Pancasila in Jakarta. Here’s how we described STARmeds at the launch meeting in April 2021: https://www.youtube.com/watch?v=Zkm0_WmiLEM
Read more about the MedsWatch Team.
You can email us through the contact form, or reach us on Twitter @MedsWatch.